Low Rate of HBV Screening Prior to Chemotherapy
Atif Zaman, MD, MPH reviewing Wi C-I et al. Clin Gastroenterol Hepatol 2015 May.
Is Hydroxyurea Underused in Sickle Cell Anemia?
David Green, MD, PhD reviewing Stettler N et al. JAMA 2015 Apr 28.
How Good Is Adherence to Dabigatran?
David Green, MD, PhD reviewing Shore S et al. JAMA 2015 Apr 14.
Oral Anticoagulant-Related Hemorrhage: Improving Management of a Risky Condition
Seemant Chaturvedi, MD reviewing Kuramatsu JB et al. JAMA 2015 Feb 24.
Patient Survival Unaffected by Age of Transfused Blood
David Green, MD, PhD reviewing Lacroix J et al. N Engl J Med 2015 Mar 17.
All-RAS-Mutation Testing for Anti-EGFR Therapy
David H. Ilson, MD, PhD reviewing Van Cutsem E et al. J Clin Oncol 2015 Mar 1.
Eliglustat for Gaucher Disease Type 1
David Green, MD, PhD reviewing Mistry PK et al. JAMA 2015 Feb 17.
Predicting Breast Cancer Risk in Black Women
Virginia Kaklamani, MD, DSc reviewing Boggs DA et al. J Clin Oncol 2015 Jan 26.
Linifanib Fails to Improve Survival in Hepatocellular Cancer
David H. Ilson, MD, PhD reviewing Cainap C et al. J Clin Oncol 2015 Jan 10.
Erlotinib Ineffective for Advanced Liver Cancer
David H. Ilson, MD, PhD